nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolutegravir—UGT1A1—Propofol—epilepsy syndrome	0.403	1	CbGbCtD
Dolutegravir—POU2F2—Ectoderm Differentiation—ARX—epilepsy syndrome	0.0122	0.0572	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—SNTA1—epilepsy syndrome	0.0111	0.0519	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—MECP2—epilepsy syndrome	0.00701	0.0329	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—ASCL1—epilepsy syndrome	0.00636	0.0298	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—MECP2—epilepsy syndrome	0.00636	0.0298	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—NF2—epilepsy syndrome	0.00596	0.0279	CbGpPWpGaD
Dolutegravir—POU2F2—Validated transcriptional targets of deltaNp63 isoforms—BDKRB2—epilepsy syndrome	0.00593	0.0278	CbGpPWpGaD
Dolutegravir—UGT1A1—Codeine and Morphine Metabolism—ABCC2—epilepsy syndrome	0.00519	0.0243	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—RET—epilepsy syndrome	0.00494	0.0232	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—ARHGEF9—epilepsy syndrome	0.00486	0.0228	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—MAP2—epilepsy syndrome	0.00482	0.0226	CbGpPWpGaD
Dolutegravir—POU2F2—Validated transcriptional targets of deltaNp63 isoforms—VDR—epilepsy syndrome	0.00462	0.0216	CbGpPWpGaD
Dolutegravir—POU2F2—Validated transcriptional targets of deltaNp63 isoforms—HES1—epilepsy syndrome	0.00452	0.0212	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—GABRA1—epilepsy syndrome	0.00441	0.0206	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—SSTR1—epilepsy syndrome	0.00441	0.0206	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—DMD—epilepsy syndrome	0.00425	0.0199	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—SSTR2—epilepsy syndrome	0.00424	0.0199	CbGpPWpGaD
Dolutegravir—UGT1A1—Porphyrin metabolism—ALAD—epilepsy syndrome	0.0041	0.0192	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—CHRNA7—epilepsy syndrome	0.0041	0.0192	CbGpPWpGaD
Dolutegravir—UGT1A1—Codeine and Morphine Metabolism—CYP2D6—epilepsy syndrome	0.00386	0.0181	CbGpPWpGaD
Dolutegravir—UGT1A1—Heme degradation—HMOX1—epilepsy syndrome	0.00361	0.0169	CbGpPWpGaD
Dolutegravir—POU2F2—Validated transcriptional targets of deltaNp63 isoforms—ATM—epilepsy syndrome	0.00356	0.0167	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—SLC1A3—epilepsy syndrome	0.00348	0.0163	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—AQP4—epilepsy syndrome	0.00348	0.0163	CbGpPWpGaD
Dolutegravir—UGT1A1—Irinotecan Pathway—ABCC2—epilepsy syndrome	0.00332	0.0156	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—CHRM2—epilepsy syndrome	0.00327	0.0153	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—BMP4—epilepsy syndrome	0.00313	0.0147	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	0.00294	0.0138	CbGpPWpGaD
Dolutegravir—UGT1A1—Irinotecan Pathway—ABCG2—epilepsy syndrome	0.00282	0.0132	CbGpPWpGaD
Dolutegravir—UGT1A1—Codeine and Morphine Metabolism—ABCB1—epilepsy syndrome	0.00276	0.0129	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	0.00267	0.0125	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—SLC6A4—epilepsy syndrome	0.00248	0.0116	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	0.00241	0.0113	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—SST—epilepsy syndrome	0.00241	0.0113	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	0.0024	0.0113	CbGpPWpGaD
Dolutegravir—POU2F2—BCR signaling pathway—FOS—epilepsy syndrome	0.00239	0.0112	CbGpPWpGaD
Dolutegravir—UGT1A1—Irinotecan Pathway—BCHE—epilepsy syndrome	0.00234	0.011	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—TH—epilepsy syndrome	0.00221	0.0104	CbGpPWpGaD
Dolutegravir—POU2F2—BCR signaling pathway—RELA—epilepsy syndrome	0.00196	0.0092	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—FYN—epilepsy syndrome	0.00186	0.0087	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	0.00183	0.00857	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	0.0018	0.00844	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	0.00173	0.00811	CbGpPWpGaD
Dolutegravir—POU2F2—BCR signaling pathway—JUN—epilepsy syndrome	0.00172	0.00806	CbGpPWpGaD
Dolutegravir—UGT1A1—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	0.00171	0.00803	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	0.00167	0.00784	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	0.00162	0.00758	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	0.0016	0.00749	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—NR3C1—epilepsy syndrome	0.00159	0.00746	CbGpPWpGaD
Dolutegravir—UGT1A1—Porphyrin metabolism—HMOX1—epilepsy syndrome	0.00157	0.00736	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	0.00152	0.00713	CbGpPWpGaD
Dolutegravir—UGT1A1—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	0.00142	0.00665	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—CCL2—epilepsy syndrome	0.00131	0.00615	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUND—epilepsy syndrome	0.00126	0.00589	CbGpPWpGaD
Dolutegravir—UGT1A1—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.00111	0.00518	CbGpPWpGaD
Dolutegravir—UGT1A1—NRF2 pathway—SLC6A8—epilepsy syndrome	0.000968	0.00454	CbGpPWpGaD
Dolutegravir—POU2F2—BCR signaling pathway—AKT1—epilepsy syndrome	0.000958	0.00449	CbGpPWpGaD
Dolutegravir—UGT1A1—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	0.000909	0.00426	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	0.000902	0.00423	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	0.0009	0.00422	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	0.000874	0.0041	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUNB—epilepsy syndrome	0.000855	0.00401	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	0.000764	0.00358	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—HES1—epilepsy syndrome	0.000664	0.00311	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	0.000655	0.00307	CbGpPWpGaD
Dolutegravir—UGT1A1—NRF2 pathway—TXNRD1—epilepsy syndrome	0.000604	0.00283	CbGpPWpGaD
Dolutegravir—Nausea—Clobazam—epilepsy syndrome	0.000531	0.00138	CcSEcCtD
Dolutegravir—Asthenia—Propofol—epilepsy syndrome	0.000531	0.00138	CcSEcCtD
Dolutegravir—Dizziness—Acetazolamide—epilepsy syndrome	0.000527	0.00137	CcSEcCtD
Dolutegravir—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000526	0.00137	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.000524	0.00136	CcSEcCtD
Dolutegravir—Pruritus—Propofol—epilepsy syndrome	0.000523	0.00136	CcSEcCtD
Dolutegravir—Abdominal pain—Diazepam—epilepsy syndrome	0.000523	0.00136	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000522	0.00136	CcSEcCtD
Dolutegravir—Fatigue—Clonazepam—epilepsy syndrome	0.000521	0.00136	CcSEcCtD
Dolutegravir—Asthenia—Midazolam—epilepsy syndrome	0.000519	0.00135	CcSEcCtD
Dolutegravir—Insomnia—Carbamazepine—epilepsy syndrome	0.000518	0.00135	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000518	0.00135	CcSEcCtD
Dolutegravir—Fatigue—Phenytoin—epilepsy syndrome	0.000517	0.00135	CcSEcCtD
Dolutegravir—Abdominal discomfort—Topiramate—epilepsy syndrome	0.000517	0.00135	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000515	0.00134	CcSEcCtD
Dolutegravir—Fatigue—Oxcarbazepine—epilepsy syndrome	0.000515	0.00134	CcSEcCtD
Dolutegravir—Hepatitis—Gabapentin—epilepsy syndrome	0.000513	0.00134	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.000513	0.00133	CcSEcCtD
Dolutegravir—Asthenia—Levetiracetam—epilepsy syndrome	0.000513	0.00133	CcSEcCtD
Dolutegravir—Pruritus—Midazolam—epilepsy syndrome	0.000512	0.00133	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—ABCC2—epilepsy syndrome	0.000509	0.00238	CbGpPWpGaD
Dolutegravir—Urinary tract disorder—Gabapentin—epilepsy syndrome	0.000507	0.00132	CcSEcCtD
Dolutegravir—Abdominal pain—Felbamate—epilepsy syndrome	0.000506	0.00132	CcSEcCtD
Dolutegravir—Vomiting—Acetazolamide—epilepsy syndrome	0.000506	0.00132	CcSEcCtD
Dolutegravir—Diarrhoea—Propofol—epilepsy syndrome	0.000506	0.00132	CcSEcCtD
Dolutegravir—Immune system disorder—Pregabalin—epilepsy syndrome	0.000506	0.00132	CcSEcCtD
Dolutegravir—Pruritus—Levetiracetam—epilepsy syndrome	0.000506	0.00132	CcSEcCtD
Dolutegravir—Neutropenia—Topiramate—epilepsy syndrome	0.000505	0.00131	CcSEcCtD
Dolutegravir—Urethral disorder—Gabapentin—epilepsy syndrome	0.000503	0.00131	CcSEcCtD
Dolutegravir—Insomnia—Lamotrigine—epilepsy syndrome	0.000501	0.0013	CcSEcCtD
Dolutegravir—Headache—Acetazolamide—epilepsy syndrome	0.000499	0.0013	CcSEcCtD
Dolutegravir—Abdominal pain—Zonisamide—epilepsy syndrome	0.000496	0.00129	CcSEcCtD
Dolutegravir—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000495	0.00129	CcSEcCtD
Dolutegravir—Asthenia—Fosphenytoin—epilepsy syndrome	0.000495	0.00129	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000495	0.00129	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000494	0.00129	CcSEcCtD
Dolutegravir—Fatigue—Carbamazepine—epilepsy syndrome	0.000494	0.00129	CcSEcCtD
Dolutegravir—Mental disorder—Pregabalin—epilepsy syndrome	0.000491	0.00128	CcSEcCtD
Dolutegravir—Dizziness—Propofol—epilepsy syndrome	0.000489	0.00127	CcSEcCtD
Dolutegravir—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000489	0.00127	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000488	0.00127	CcSEcCtD
Dolutegravir—Pruritus—Fosphenytoin—epilepsy syndrome	0.000488	0.00127	CcSEcCtD
Dolutegravir—Hypersensitivity—Diazepam—epilepsy syndrome	0.000488	0.00127	CcSEcCtD
Dolutegravir—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000487	0.00127	CcSEcCtD
Dolutegravir—Vertigo—Valproic Acid—epilepsy syndrome	0.000484	0.00126	CcSEcCtD
Dolutegravir—Asthenia—Vigabatrin—epilepsy syndrome	0.000482	0.00126	CcSEcCtD
Dolutegravir—Flatulence—Pregabalin—epilepsy syndrome	0.00048	0.00125	CcSEcCtD
Dolutegravir—Dizziness—Midazolam—epilepsy syndrome	0.000478	0.00125	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000478	0.00124	CcSEcCtD
Dolutegravir—Abdominal pain—Clonazepam—epilepsy syndrome	0.000478	0.00124	CcSEcCtD
Dolutegravir—Fatigue—Lamotrigine—epilepsy syndrome	0.000477	0.00124	CcSEcCtD
Dolutegravir—Pruritus—Vigabatrin—epilepsy syndrome	0.000476	0.00124	CcSEcCtD
Dolutegravir—Asthenia—Diazepam—epilepsy syndrome	0.000475	0.00124	CcSEcCtD
Dolutegravir—Renal failure—Topiramate—epilepsy syndrome	0.000473	0.00123	CcSEcCtD
Dolutegravir—Nausea—Acetazolamide—epilepsy syndrome	0.000473	0.00123	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—SLC6A1—epilepsy syndrome	0.000473	0.00222	CbGpPWpGaD
Dolutegravir—Dizziness—Levetiracetam—epilepsy syndrome	0.000473	0.00123	CcSEcCtD
Dolutegravir—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000472	0.00123	CcSEcCtD
Dolutegravir—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000472	0.00123	CcSEcCtD
Dolutegravir—Vomiting—Propofol—epilepsy syndrome	0.00047	0.00122	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000468	0.00122	CcSEcCtD
Dolutegravir—Pruritus—Diazepam—epilepsy syndrome	0.000468	0.00122	CcSEcCtD
Dolutegravir—Rash—Propofol—epilepsy syndrome	0.000466	0.00121	CcSEcCtD
Dolutegravir—Dermatitis—Propofol—epilepsy syndrome	0.000466	0.00121	CcSEcCtD
Dolutegravir—Immune system disorder—Gabapentin—epilepsy syndrome	0.000464	0.00121	CcSEcCtD
Dolutegravir—Headache—Propofol—epilepsy syndrome	0.000463	0.00121	CcSEcCtD
Dolutegravir—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000462	0.0012	CcSEcCtD
Dolutegravir—Vomiting—Midazolam—epilepsy syndrome	0.00046	0.0012	CcSEcCtD
Dolutegravir—Diarrhoea—Vigabatrin—epilepsy syndrome	0.00046	0.0012	CcSEcCtD
Dolutegravir—Asthenia—Felbamate—epilepsy syndrome	0.00046	0.0012	CcSEcCtD
Dolutegravir—Rash—Midazolam—epilepsy syndrome	0.000456	0.00119	CcSEcCtD
Dolutegravir—Dizziness—Fosphenytoin—epilepsy syndrome	0.000456	0.00119	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000456	0.00119	CcSEcCtD
Dolutegravir—Dermatitis—Midazolam—epilepsy syndrome	0.000456	0.00119	CcSEcCtD
Dolutegravir—Vomiting—Levetiracetam—epilepsy syndrome	0.000454	0.00118	CcSEcCtD
Dolutegravir—Headache—Midazolam—epilepsy syndrome	0.000453	0.00118	CcSEcCtD
Dolutegravir—Pruritus—Felbamate—epilepsy syndrome	0.000453	0.00118	CcSEcCtD
Dolutegravir—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000453	0.00118	CcSEcCtD
Dolutegravir—Diarrhoea—Diazepam—epilepsy syndrome	0.000453	0.00118	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000453	0.00118	CcSEcCtD
Dolutegravir—Rash—Levetiracetam—epilepsy syndrome	0.000451	0.00117	CcSEcCtD
Dolutegravir—Dermatitis—Levetiracetam—epilepsy syndrome	0.00045	0.00117	CcSEcCtD
Dolutegravir—Asthenia—Zonisamide—epilepsy syndrome	0.00045	0.00117	CcSEcCtD
Dolutegravir—Mental disorder—Gabapentin—epilepsy syndrome	0.00045	0.00117	CcSEcCtD
Dolutegravir—Headache—Levetiracetam—epilepsy syndrome	0.000448	0.00117	CcSEcCtD
Dolutegravir—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000445	0.00116	CcSEcCtD
Dolutegravir—Dizziness—Vigabatrin—epilepsy syndrome	0.000445	0.00116	CcSEcCtD
Dolutegravir—Pruritus—Zonisamide—epilepsy syndrome	0.000444	0.00115	CcSEcCtD
Dolutegravir—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000442	0.00115	CcSEcCtD
Dolutegravir—Flatulence—Gabapentin—epilepsy syndrome	0.00044	0.00115	CcSEcCtD
Dolutegravir—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.00044	0.00115	CcSEcCtD
Dolutegravir—Nausea—Propofol—epilepsy syndrome	0.000439	0.00114	CcSEcCtD
Dolutegravir—Vomiting—Fosphenytoin—epilepsy syndrome	0.000438	0.00114	CcSEcCtD
Dolutegravir—Diarrhoea—Felbamate—epilepsy syndrome	0.000438	0.00114	CcSEcCtD
Dolutegravir—Vertigo—Pregabalin—epilepsy syndrome	0.000438	0.00114	CcSEcCtD
Dolutegravir—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000438	0.00114	CcSEcCtD
Dolutegravir—Dizziness—Diazepam—epilepsy syndrome	0.000438	0.00114	CcSEcCtD
Dolutegravir—Rash—Fosphenytoin—epilepsy syndrome	0.000435	0.00113	CcSEcCtD
Dolutegravir—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000434	0.00113	CcSEcCtD
Dolutegravir—Asthenia—Clonazepam—epilepsy syndrome	0.000434	0.00113	CcSEcCtD
Dolutegravir—Headache—Fosphenytoin—epilepsy syndrome	0.000432	0.00112	CcSEcCtD
Dolutegravir—Hepatitis—Topiramate—epilepsy syndrome	0.000432	0.00112	CcSEcCtD
Dolutegravir—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000432	0.00112	CcSEcCtD
Dolutegravir—Asthenia—Phenytoin—epilepsy syndrome	0.000431	0.00112	CcSEcCtD
Dolutegravir—Nausea—Midazolam—epilepsy syndrome	0.00043	0.00112	CcSEcCtD
Dolutegravir—Diarrhoea—Zonisamide—epilepsy syndrome	0.000429	0.00112	CcSEcCtD
Dolutegravir—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000428	0.00112	CcSEcCtD
Dolutegravir—Pruritus—Clonazepam—epilepsy syndrome	0.000428	0.00111	CcSEcCtD
Dolutegravir—Vomiting—Vigabatrin—epilepsy syndrome	0.000427	0.00111	CcSEcCtD
Dolutegravir—Skin disorder—Valproic Acid—epilepsy syndrome	0.000427	0.00111	CcSEcCtD
Dolutegravir—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000427	0.00111	CcSEcCtD
Dolutegravir—Pruritus—Phenytoin—epilepsy syndrome	0.000425	0.00111	CcSEcCtD
Dolutegravir—Nausea—Levetiracetam—epilepsy syndrome	0.000424	0.00111	CcSEcCtD
Dolutegravir—Rash—Vigabatrin—epilepsy syndrome	0.000424	0.0011	CcSEcCtD
Dolutegravir—Dizziness—Felbamate—epilepsy syndrome	0.000424	0.0011	CcSEcCtD
Dolutegravir—Dermatitis—Vigabatrin—epilepsy syndrome	0.000423	0.0011	CcSEcCtD
Dolutegravir—Urethral disorder—Topiramate—epilepsy syndrome	0.000423	0.0011	CcSEcCtD
Dolutegravir—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000422	0.0011	CcSEcCtD
Dolutegravir—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000422	0.0011	CcSEcCtD
Dolutegravir—Headache—Vigabatrin—epilepsy syndrome	0.000421	0.0011	CcSEcCtD
Dolutegravir—Vomiting—Diazepam—epilepsy syndrome	0.000421	0.0011	CcSEcCtD
Dolutegravir—Rash—Diazepam—epilepsy syndrome	0.000417	0.00109	CcSEcCtD
Dolutegravir—Dermatitis—Diazepam—epilepsy syndrome	0.000417	0.00109	CcSEcCtD
Dolutegravir—Dizziness—Zonisamide—epilepsy syndrome	0.000415	0.00108	CcSEcCtD
Dolutegravir—Headache—Diazepam—epilepsy syndrome	0.000415	0.00108	CcSEcCtD
Dolutegravir—Diarrhoea—Clonazepam—epilepsy syndrome	0.000413	0.00108	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000412	0.00107	CcSEcCtD
Dolutegravir—Asthenia—Carbamazepine—epilepsy syndrome	0.000411	0.00107	CcSEcCtD
Dolutegravir—Diarrhoea—Phenytoin—epilepsy syndrome	0.000411	0.00107	CcSEcCtD
Dolutegravir—Nausea—Fosphenytoin—epilepsy syndrome	0.00041	0.00107	CcSEcCtD
Dolutegravir—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000409	0.00106	CcSEcCtD
Dolutegravir—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000408	0.00106	CcSEcCtD
Dolutegravir—Vomiting—Felbamate—epilepsy syndrome	0.000407	0.00106	CcSEcCtD
Dolutegravir—Pruritus—Carbamazepine—epilepsy syndrome	0.000405	0.00106	CcSEcCtD
Dolutegravir—Rash—Felbamate—epilepsy syndrome	0.000404	0.00105	CcSEcCtD
Dolutegravir—Dermatitis—Felbamate—epilepsy syndrome	0.000403	0.00105	CcSEcCtD
Dolutegravir—Vertigo—Gabapentin—epilepsy syndrome	0.000402	0.00105	CcSEcCtD
Dolutegravir—Headache—Felbamate—epilepsy syndrome	0.000401	0.00104	CcSEcCtD
Dolutegravir—Dizziness—Clonazepam—epilepsy syndrome	0.0004	0.00104	CcSEcCtD
Dolutegravir—Nausea—Vigabatrin—epilepsy syndrome	0.000399	0.00104	CcSEcCtD
Dolutegravir—Vomiting—Zonisamide—epilepsy syndrome	0.000399	0.00104	CcSEcCtD
Dolutegravir—Insomnia—Valproic Acid—epilepsy syndrome	0.000398	0.00104	CcSEcCtD
Dolutegravir—Asthenia—Lamotrigine—epilepsy syndrome	0.000397	0.00103	CcSEcCtD
Dolutegravir—Dizziness—Phenytoin—epilepsy syndrome	0.000397	0.00103	CcSEcCtD
Dolutegravir—Rash—Zonisamide—epilepsy syndrome	0.000395	0.00103	CcSEcCtD
Dolutegravir—Dermatitis—Zonisamide—epilepsy syndrome	0.000395	0.00103	CcSEcCtD
Dolutegravir—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000395	0.00103	CcSEcCtD
Dolutegravir—Nausea—Diazepam—epilepsy syndrome	0.000393	0.00102	CcSEcCtD
Dolutegravir—Headache—Zonisamide—epilepsy syndrome	0.000393	0.00102	CcSEcCtD
Dolutegravir—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000392	0.00102	CcSEcCtD
Dolutegravir—Pruritus—Lamotrigine—epilepsy syndrome	0.000392	0.00102	CcSEcCtD
Dolutegravir—Immune system disorder—Topiramate—epilepsy syndrome	0.00039	0.00102	CcSEcCtD
Dolutegravir—Nervous system disorder—Pregabalin—epilepsy syndrome	0.00039	0.00102	CcSEcCtD
Dolutegravir—Skin disorder—Pregabalin—epilepsy syndrome	0.000386	0.00101	CcSEcCtD
Dolutegravir—Vomiting—Clonazepam—epilepsy syndrome	0.000384	0.001	CcSEcCtD
Dolutegravir—Vomiting—Phenytoin—epilepsy syndrome	0.000382	0.000994	CcSEcCtD
Dolutegravir—Rash—Clonazepam—epilepsy syndrome	0.000381	0.000992	CcSEcCtD
Dolutegravir—Dermatitis—Clonazepam—epilepsy syndrome	0.000381	0.000991	CcSEcCtD
Dolutegravir—Nausea—Felbamate—epilepsy syndrome	0.00038	0.000991	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.00038	0.000989	CcSEcCtD
Dolutegravir—Vomiting—Oxcarbazepine—epilepsy syndrome	0.00038	0.000988	CcSEcCtD
Dolutegravir—Fatigue—Valproic Acid—epilepsy syndrome	0.000379	0.000988	CcSEcCtD
Dolutegravir—Dizziness—Carbamazepine—epilepsy syndrome	0.000379	0.000986	CcSEcCtD
Dolutegravir—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000379	0.000986	CcSEcCtD
Dolutegravir—Headache—Clonazepam—epilepsy syndrome	0.000379	0.000986	CcSEcCtD
Dolutegravir—Rash—Phenytoin—epilepsy syndrome	0.000378	0.000985	CcSEcCtD
Dolutegravir—Mental disorder—Topiramate—epilepsy syndrome	0.000378	0.000985	CcSEcCtD
Dolutegravir—Dermatitis—Phenytoin—epilepsy syndrome	0.000378	0.000984	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—SLC6A4—epilepsy syndrome	0.000378	0.00177	CbGpPWpGaD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000378	0.000984	CcSEcCtD
Dolutegravir—Rash—Oxcarbazepine—epilepsy syndrome	0.000376	0.00098	CcSEcCtD
Dolutegravir—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000376	0.000979	CcSEcCtD
Dolutegravir—Headache—Phenytoin—epilepsy syndrome	0.000376	0.000979	CcSEcCtD
Dolutegravir—Headache—Oxcarbazepine—epilepsy syndrome	0.000374	0.000974	CcSEcCtD
Dolutegravir—Nausea—Zonisamide—epilepsy syndrome	0.000372	0.00097	CcSEcCtD
Dolutegravir—Flatulence—Topiramate—epilepsy syndrome	0.000371	0.000965	CcSEcCtD
Dolutegravir—UGT1A1—Biological oxidations—CYP2C19—epilepsy syndrome	0.00037	0.00173	CbGpPWpGaD
Dolutegravir—UGT1A1—Biological oxidations—CYP11A1—epilepsy syndrome	0.000367	0.00172	CbGpPWpGaD
Dolutegravir—Dizziness—Lamotrigine—epilepsy syndrome	0.000366	0.000953	CcSEcCtD
Dolutegravir—UGT1A1—Metapathway biotransformation—CYP2C19—epilepsy syndrome	0.000365	0.00171	CbGpPWpGaD
Dolutegravir—Vomiting—Carbamazepine—epilepsy syndrome	0.000364	0.000948	CcSEcCtD
Dolutegravir—UGT1A1—Metapathway biotransformation—CYP11A1—epilepsy syndrome	0.000362	0.0017	CbGpPWpGaD
Dolutegravir—Rash—Carbamazepine—epilepsy syndrome	0.000361	0.000941	CcSEcCtD
Dolutegravir—Dermatitis—Carbamazepine—epilepsy syndrome	0.000361	0.00094	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.00036	0.000937	CcSEcCtD
Dolutegravir—Insomnia—Pregabalin—epilepsy syndrome	0.00036	0.000937	CcSEcCtD
Dolutegravir—Nausea—Clonazepam—epilepsy syndrome	0.000359	0.000935	CcSEcCtD
Dolutegravir—Headache—Carbamazepine—epilepsy syndrome	0.000359	0.000935	CcSEcCtD
Dolutegravir—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000358	0.000931	CcSEcCtD
Dolutegravir—Nausea—Phenytoin—epilepsy syndrome	0.000357	0.000928	CcSEcCtD
Dolutegravir—Nausea—Oxcarbazepine—epilepsy syndrome	0.000355	0.000923	CcSEcCtD
Dolutegravir—Skin disorder—Gabapentin—epilepsy syndrome	0.000354	0.000923	CcSEcCtD
Dolutegravir—Vomiting—Lamotrigine—epilepsy syndrome	0.000352	0.000917	CcSEcCtD
Dolutegravir—Rash—Lamotrigine—epilepsy syndrome	0.000349	0.000909	CcSEcCtD
Dolutegravir—Dermatitis—Lamotrigine—epilepsy syndrome	0.000349	0.000908	CcSEcCtD
Dolutegravir—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000348	0.000906	CcSEcCtD
Dolutegravir—Headache—Lamotrigine—epilepsy syndrome	0.000347	0.000903	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—epilepsy syndrome	0.000346	0.00162	CbGpPWpGaD
Dolutegravir—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000343	0.000894	CcSEcCtD
Dolutegravir—Fatigue—Pregabalin—epilepsy syndrome	0.000343	0.000893	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—SLC2A1—epilepsy syndrome	0.000342	0.0016	CbGpPWpGaD
Dolutegravir—Nausea—Carbamazepine—epilepsy syndrome	0.00034	0.000886	CcSEcCtD
Dolutegravir—Vertigo—Topiramate—epilepsy syndrome	0.000338	0.00088	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	0.000336	0.00157	CbGpPWpGaD
Dolutegravir—UGT1A1—Biological oxidations—CYP2D6—epilepsy syndrome	0.000332	0.00155	CbGpPWpGaD
Dolutegravir—Insomnia—Gabapentin—epilepsy syndrome	0.00033	0.000859	CcSEcCtD
Dolutegravir—Nausea—Lamotrigine—epilepsy syndrome	0.000329	0.000856	CcSEcCtD
Dolutegravir—UGT1A1—Metapathway biotransformation—CYP2D6—epilepsy syndrome	0.000327	0.00153	CbGpPWpGaD
Dolutegravir—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000325	0.000847	CcSEcCtD
Dolutegravir—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000324	0.000844	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—HBEGF—epilepsy syndrome	0.000321	0.00151	CbGpPWpGaD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000318	0.000828	CcSEcCtD
Dolutegravir—Asthenia—Valproic Acid—epilepsy syndrome	0.000316	0.000822	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000315	0.00082	CcSEcCtD
Dolutegravir—Fatigue—Gabapentin—epilepsy syndrome	0.000314	0.000819	CcSEcCtD
Dolutegravir—Abdominal pain—Pregabalin—epilepsy syndrome	0.000314	0.000819	CcSEcCtD
Dolutegravir—Pruritus—Valproic Acid—epilepsy syndrome	0.000311	0.000811	CcSEcCtD
Dolutegravir—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000301	0.000784	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	0.000301	0.00141	CbGpPWpGaD
Dolutegravir—Nervous system disorder—Topiramate—epilepsy syndrome	0.000301	0.000784	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000298	0.000777	CcSEcCtD
Dolutegravir—Skin disorder—Topiramate—epilepsy syndrome	0.000298	0.000776	CcSEcCtD
Dolutegravir—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000293	0.000763	CcSEcCtD
Dolutegravir—Dizziness—Valproic Acid—epilepsy syndrome	0.000291	0.000758	CcSEcCtD
Dolutegravir—Abdominal pain—Gabapentin—epilepsy syndrome	0.000288	0.000751	CcSEcCtD
Dolutegravir—Asthenia—Pregabalin—epilepsy syndrome	0.000285	0.000743	CcSEcCtD
Dolutegravir—Pruritus—Pregabalin—epilepsy syndrome	0.000281	0.000733	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—HMOX1—epilepsy syndrome	0.000281	0.00132	CbGpPWpGaD
Dolutegravir—Vomiting—Valproic Acid—epilepsy syndrome	0.00028	0.000728	CcSEcCtD
Dolutegravir—Insomnia—Topiramate—epilepsy syndrome	0.000278	0.000723	CcSEcCtD
Dolutegravir—Rash—Valproic Acid—epilepsy syndrome	0.000277	0.000722	CcSEcCtD
Dolutegravir—Dermatitis—Valproic Acid—epilepsy syndrome	0.000277	0.000722	CcSEcCtD
Dolutegravir—Headache—Valproic Acid—epilepsy syndrome	0.000276	0.000718	CcSEcCtD
Dolutegravir—Diarrhoea—Pregabalin—epilepsy syndrome	0.000272	0.000709	CcSEcCtD
Dolutegravir—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000269	0.0007	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000265	0.00069	CcSEcCtD
Dolutegravir—Fatigue—Topiramate—epilepsy syndrome	0.000265	0.000689	CcSEcCtD
Dolutegravir—Dizziness—Pregabalin—epilepsy syndrome	0.000263	0.000685	CcSEcCtD
Dolutegravir—Asthenia—Gabapentin—epilepsy syndrome	0.000262	0.000681	CcSEcCtD
Dolutegravir—Nausea—Valproic Acid—epilepsy syndrome	0.000261	0.00068	CcSEcCtD
Dolutegravir—Pruritus—Gabapentin—epilepsy syndrome	0.000258	0.000672	CcSEcCtD
Dolutegravir—Vomiting—Pregabalin—epilepsy syndrome	0.000253	0.000659	CcSEcCtD
Dolutegravir—UGT1A1—Metabolism—CA13—epilepsy syndrome	0.000253	0.00119	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	0.000251	0.00118	CbGpPWpGaD
Dolutegravir—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000251	0.000653	CcSEcCtD
Dolutegravir—Rash—Pregabalin—epilepsy syndrome	0.000251	0.000653	CcSEcCtD
Dolutegravir—Dermatitis—Pregabalin—epilepsy syndrome	0.000251	0.000652	CcSEcCtD
Dolutegravir—Diarrhoea—Gabapentin—epilepsy syndrome	0.00025	0.00065	CcSEcCtD
Dolutegravir—Headache—Pregabalin—epilepsy syndrome	0.000249	0.000649	CcSEcCtD
Dolutegravir—Abdominal pain—Topiramate—epilepsy syndrome	0.000243	0.000632	CcSEcCtD
Dolutegravir—Dizziness—Gabapentin—epilepsy syndrome	0.000241	0.000628	CcSEcCtD
Dolutegravir—Nausea—Pregabalin—epilepsy syndrome	0.000236	0.000615	CcSEcCtD
Dolutegravir—Vomiting—Gabapentin—epilepsy syndrome	0.000232	0.000604	CcSEcCtD
Dolutegravir—Rash—Gabapentin—epilepsy syndrome	0.00023	0.000599	CcSEcCtD
Dolutegravir—Dermatitis—Gabapentin—epilepsy syndrome	0.00023	0.000598	CcSEcCtD
Dolutegravir—Headache—Gabapentin—epilepsy syndrome	0.000229	0.000595	CcSEcCtD
Dolutegravir—Hypersensitivity—Topiramate—epilepsy syndrome	0.000226	0.000589	CcSEcCtD
Dolutegravir—Asthenia—Topiramate—epilepsy syndrome	0.00022	0.000573	CcSEcCtD
Dolutegravir—Pruritus—Topiramate—epilepsy syndrome	0.000217	0.000565	CcSEcCtD
Dolutegravir—Nausea—Gabapentin—epilepsy syndrome	0.000217	0.000564	CcSEcCtD
Dolutegravir—Diarrhoea—Topiramate—epilepsy syndrome	0.00021	0.000547	CcSEcCtD
Dolutegravir—Dizziness—Topiramate—epilepsy syndrome	0.000203	0.000528	CcSEcCtD
Dolutegravir—Vomiting—Topiramate—epilepsy syndrome	0.000195	0.000508	CcSEcCtD
Dolutegravir—Rash—Topiramate—epilepsy syndrome	0.000193	0.000504	CcSEcCtD
Dolutegravir—Dermatitis—Topiramate—epilepsy syndrome	0.000193	0.000503	CcSEcCtD
Dolutegravir—Headache—Topiramate—epilepsy syndrome	0.000192	0.000501	CcSEcCtD
Dolutegravir—UGT1A1—Metabolism—FAR1—epilepsy syndrome	0.000192	0.000898	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ADK—epilepsy syndrome	0.000192	0.000898	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GLUD1—epilepsy syndrome	0.000192	0.000898	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—L2HGDH—epilepsy syndrome	0.000192	0.000898	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PDXK—epilepsy syndrome	0.000192	0.000898	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CERS1—epilepsy syndrome	0.000192	0.000898	CbGpPWpGaD
Dolutegravir—Nausea—Topiramate—epilepsy syndrome	0.000182	0.000475	CcSEcCtD
Dolutegravir—UGT1A1—Metabolism—GAMT—epilepsy syndrome	0.000175	0.000822	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—NHLRC1—epilepsy syndrome	0.000175	0.000822	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—EPM2A—epilepsy syndrome	0.000175	0.000822	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PNPO—epilepsy syndrome	0.000175	0.000822	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—QDPR—epilepsy syndrome	0.000163	0.000764	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CA4—epilepsy syndrome	0.000163	0.000764	CbGpPWpGaD
Dolutegravir—UGT1A1—Biological oxidations—POMC—epilepsy syndrome	0.000162	0.000761	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—COX3—epilepsy syndrome	0.000153	0.000718	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SLCO1A2—epilepsy syndrome	0.000145	0.000681	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CACNA2D2—epilepsy syndrome	0.000145	0.000681	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—KCNB1—epilepsy syndrome	0.000145	0.000681	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PFKL—epilepsy syndrome	0.000145	0.000681	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SLC6A8—epilepsy syndrome	0.000145	0.000681	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ATIC—epilepsy syndrome	0.000133	0.000623	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—NEU1—epilepsy syndrome	0.000133	0.000623	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—UPB1—epilepsy syndrome	0.000133	0.000623	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—HSD17B4—epilepsy syndrome	0.000128	0.000599	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PPP1R3C—epilepsy syndrome	0.000124	0.000579	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GBE1—epilepsy syndrome	0.000124	0.000579	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ASAH1—epilepsy syndrome	0.000116	0.000544	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—STXBP1—epilepsy syndrome	0.000113	0.000529	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—NT5E—epilepsy syndrome	0.00011	0.000516	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ALAD—epilepsy syndrome	0.00011	0.000516	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ALDH7A1—epilepsy syndrome	0.000105	0.000492	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CACNA1A—epilepsy syndrome	0.000105	0.000492	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ST3GAL3—epilepsy syndrome	0.000103	0.000482	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ADSL—epilepsy syndrome	0.000101	0.000472	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GLUL—epilepsy syndrome	9.87e-05	0.000463	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CACNA1D—epilepsy syndrome	9.69e-05	0.000454	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—TXNRD1—epilepsy syndrome	9.07e-05	0.000425	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—AQP1—epilepsy syndrome	8.8e-05	0.000412	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CHRM3—epilepsy syndrome	7.96e-05	0.000373	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—KCNJ11—epilepsy syndrome	7.96e-05	0.000373	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ABCG2—epilepsy syndrome	6.49e-05	0.000304	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYP2C19—epilepsy syndrome	6.32e-05	0.000296	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYP11A1—epilepsy syndrome	6.28e-05	0.000294	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYP2D6—epilepsy syndrome	5.67e-05	0.000266	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ADRA2A—epilepsy syndrome	5.4e-05	0.000253	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—BCHE—epilepsy syndrome	5.38e-05	0.000252	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SLC2A1—epilepsy syndrome	5.13e-05	0.00024	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PLCB1—epilepsy syndrome	5.07e-05	0.000238	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—TH—epilepsy syndrome	5.05e-05	0.000237	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—HMOX1—epilepsy syndrome	4.22e-05	0.000198	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CAT—epilepsy syndrome	4.16e-05	0.000195	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ABCB1—epilepsy syndrome	4.05e-05	0.00019	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GPX1—epilepsy syndrome	3.76e-05	0.000176	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—AGT—epilepsy syndrome	3.3e-05	0.000155	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—APOE—epilepsy syndrome	3.23e-05	0.000152	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—POMC—epilepsy syndrome	2.78e-05	0.00013	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ALB—epilepsy syndrome	2.53e-05	0.000119	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PTGS2—epilepsy syndrome	2.22e-05	0.000104	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—AKT1—epilepsy syndrome	1.11e-05	5.22e-05	CbGpPWpGaD
